PATENT CLAIM ANALYSIS

Application Number: 15882400
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "094100"]

Abstract:
The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.

Claim (Index 18):
The method of  claim 12 , wherein the collagen-containing tissue matrix is produced from tissue derived from a tissue selected from skin fascia, adipose, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, muscle, and intestinal tissue.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 86.0
- Lexical Diversity: 1.41667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13813814', '12231361', '10895961', '14696390', '13517906']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7045789164015082
- 35 USC 102 Novelty (BERT): 0.4879436534170809
- Combined Prediction Score: 0.6829153901030655
- Mean Citation Score: 156.113868
- Max Citation Score: 162.29962
- Similarity Product: 106.7492779879725

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test